SOLANEZUMAB

UNII:	5D6PWO0333
Formula:
Preferred Substance Name:	SOLANEZUMAB

955085-14-0
IMMUNOGLOBULIN G1, ANTI-(HUMAN .BETA.-AMYLOID PEPTIDE) (HUMANIZED MONOCLONAL LY2062430 HEAVY CHAIN, DISULFIDE WITH HUMANIZED MONOCLONAL LY2062430 LIGHT CHAIN, DIMER)
IMMUNOGLOBULIN G1, ANTI-(HUMAN .BETA.-AMYLOID PEPTIDE) (HUMANIZED MONOCLONAL LY2062430 HEAVY CHAIN, DISULPHIDE WITH HUMANIZED MONOCLONAL LY2062430 LIGHT CHAIN, DIMER)
IMMUNOGLOBULIN G1, ANTI-(HUMAN .BETA.-AMYLOID) (HUMAN-MOUSE MONOCLONAL LY2062430 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL LY2062430 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN .BETA.-AMYLOID) (HUMAN-MOUSE MONOCLONAL LY2062430 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL LY2062430 LIGHT CHAIN, DIMER
LY2062430
LY-2062430
SOLANEZUMAB [INN]
SOLANEZUMAB [JAN]
SOLANEZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SOLANEZUMAB

Synonyms and Mappings

Resources